Coronavirus membrane fusion mechanism offers a potential target for antiviral development

The coronavirus disease 2019 (COVID-19) pandemic has focused attention on the need to develop effective therapies against the causative agent, SARS-CoV-2, and also against other pathogenic coronaviruses (CoV) that have emerged in the past or might appear in future. Researchers are therefore focusing...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Tiffany, Bidon, Miya, Jaimes, Javier A., Whittaker, Gary R., Daniel, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194977/
https://www.ncbi.nlm.nih.gov/pubmed/32272173
http://dx.doi.org/10.1016/j.antiviral.2020.104792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194977/
https://www.ncbi.nlm.nih.gov/pubmed/32272173
http://dx.doi.org/10.1016/j.antiviral.2020.104792

Ejemplares similares